Golgi Cells, named after Camillo Golgi, the Italian neuroscientist who discovered them, are specialized inhibitory interneurons primarily found in the granular layer of the cerebellum, a region crucial for motor coordination and control. These small, stellate-shaped cells play a pivotal role in regulating information flow within the cerebellar circuitry. Golgi cells receive inputs from mossy fibers, which convey sensory and motor information, and exert inhibitory control over granule cells through the release of neurotransmitters like gamma-aminobutyric acid (GABA). By fine-tuning the activity of granule cells, Golgi cells contribute to the precise modulation of cerebellar output. This regulation is essential for coordinating voluntary movements, maintaining balance, and adapting motor responses. Dysfunction in Golgi cells is implicated in cerebellar disorders and ataxias. Research on Golgi cells contributes to our understanding of cerebellar function and its role in motor learning and coordination. Investigating the complex interplay between different cell types within the cerebellum, including Golgi cells, provides insights into the neural mechanisms underlying motor control and coordination. The study of Golgi cells continues to be an active area of research, offering potential avenues for therapeutic interventions in neurological conditions affecting motor function.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States